Takara Bio

Takara Bio is a leading supplier in the life science field, who develops, manufactures, and distributes a wide range of life science reagents under the Takara™, Clontech®, and Cellartis® brands.

Key products include SMART cDNA synthesis kits for a variety of samples and applications, including NGS, high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes), Cellartis stem cells and stem cell reagents, RT enzymes and SMART library construction kits, the innovative In-Fusion® cloning system, Guide-it gene editing tools, Tet-based inducible gene expression systems, and Living Colors® fluorescent proteins.

Recently, Takara Bio acquired Rubicon Genomics and WaferGen Bio-systems. As part of the Takara Bio family, they expand our NGS portfolio as well as add R&D, manufacturing, and support for automation systems for NGS and qPCR applications. Takara Bio’s portfolio supports applications including NGS, gene discovery, regulation, and function studies, as well as genetic analysis, protein expression and purification, gene editing, stem cell studies, and plant and food research.

Application Note: Full-length, single-cell RNA-seq with the SMARTer™ ICELL8® Single-Cell System

Application note: Cellartis® Power™ Primary HEP Medium – extend functionality of your primary hepatocytes to 4 weeks

Novel vectors for more efficient and less risky ocular gene therapy

Using cholangiocyte organoids to regenerate human bile ducts

Drug Target Review Cell & Gene Therapy ebook 2021

NGS In-Depth Focus 2020

Expert view: The development of single‑cell genomics with Smart‑seq

Next-Generation Sequencing In-Depth Focus 2018

Expert view: Overcoming the problems of working with human primary hepatocytes

Stem Cells In-Depth Focus 2018

Expert view: Single-cell sequencing in basic research and clinical applications

NGS In-Depth Focus 2017

Stem Cells In-Depth Focus 2017

Product Hub: The growing potential of hiPS-derived beta cells

Stem Cells In-Depth Focus 2016

Capturing biological complexity to empower biomarker discovery